Effective inhibition of Clostridioides difficile by the novel peptide CM-A.
Clostridioides difficile infection is the most common cause of nosocomial and antibiotic-associated diarrhea. C. difficile treatment is increasingly likely to fail, and the recurrence rate is high. Antimicrobial peptides are considered an alternative treatment for many infectious diseases, including...
Enregistré dans:
Auteurs principaux: | Sirirak Arthithanyaroj, Surang Chankhamhaengdecha, Urai Chaisri, Ratchaneewan Aunpad, Amornrat Aroonnual |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fe207abfbfb442eaa7f132fa99f6e14b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Epidemiology of Clostridioides difficile in South Africa.
par: Pieter de Jager, et autres
Publié: (2021) -
Raja 42, a novel gamma lactam compound, is effective against Clostridioides difficile.
par: Alexis Fong, et autres
Publié: (2021) -
Faecal transplantation and Clostridioides difficile infection
par: Knežević Darija A., et autres
Publié: (2021) -
Biofilm regulation in Clostridioides difficile: Novel systems linked to hypervirulence.
par: Megan G Taggart, et autres
Publié: (2021) -
High-throughput screening identifies a novel natural product-inspired scaffold capable of inhibiting Clostridioides difficile in vitro
par: Rusha Pal, et autres
Publié: (2021)